Evidence map›Paper›PMID 39060113›Full record

ArticleLife science alliance2024

Gene expression and chromatin conformation of microglia in virally suppressed people with HIV.

Johannes Cm Schlachetzki, Sara Gianella, Zhengyu Ouyang, Addison J Lana, Xiaoxu Yang, Sydney O'Brien, Jean F Challacombe, Peter J Gaskill, Kelly L Jordan-Sciutto, Antoine Chaillon and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Life science alliance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Johannes Cm SchlachetzkiDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA jschlachetzki@ucsd.edu.ORCID 0000-0002-7801-9743
Sara GianellaDepartment of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
Zhengyu OuyangDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.
Addison J LanaDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.
Xiaoxu YangDepartment of Human Genetics, University of Utah, Salt Lake City, UT, USA.
Sydney O'BrienDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.
Jean F ChallacombeDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA.
Peter J GaskillDepartment of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-0095-5424
Kelly L Jordan-SciuttoDepartment of Oral Medicine, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-0827-1337
Antoine ChaillonDepartment of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.
David MooreDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Cristian L AchimDepartment of Pathology, University of California San Diego, San Diego, CA, USA.
Ronald J EllisDepartment of Neurosciences, University of California San Diego, San Diego, CA, USA.ORCID 0000-0003-4931-752X
Davey M SmithDepartment of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA, USA.ORCID 0000-0003-3603-1733
Christopher K GlassDepartment of Cellular and Molecular Medicine, University of California San Diego, San Diego, CA, USA ckg@ucsd.edu.ORCID 0000-0003-4344-3592

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
Project-004P01AI169609 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 2022 to 2026
$10.6M
Brain Myeloid Cells are Sources of HIV-associated Damage and Viral DispersalR01DA055491 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHAILLON, ANTOINE · 2021 to 2025
$3.6M
Defining the cell-specific epigenetic landscape leading to altered gene expression signatures in HIV-Associated Neurocognitive DisorderRF1AG061060 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2018 to 2018
$2.7M
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIVR61DA058501 · NIDA · DREXEL UNIVERSITY · PI GASKILL, PETER JESSE · 2023 to 2024
$1.1M
Mechanisms controlling HIV latency and pathogenesis in microgliaR21MH134401 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHLACHETZKI, JOHANNES CAROLUS MAGNUS, YANG, XIAOXU · 2023 to 2023
$435k
Understanding genomic stability betweengenerations by assessing mutational burdens in single spermsK99HD111686 · NICHD · UNIVERSITY OF UTAH · PI YANG, XIAOXU · 2023 to 2024
$232k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P01 AI169609NIAID NIH HHS P30 AI036214NIAID NIH HHS UM1 AI164559NIA NIH HHS RF1 AG061060NICHD NIH HHS K99 HD111686NIDA NIH HHS R01 DA055491NIMH NIH HHS P30 MH062512NIMH NIH HHS R21 MH134401NIMH NIH HHS U24 MH100928
6 · The paper itself

Abstract

The presence of HIV in sequestered reservoirs is a central impediment to a functional cure, allowing HIV to persist despite life-long antiretroviral therapy (ART), and driving a variety of comorbid conditions. Our understanding of the latent HIV reservoir in the central nervous system is incomplete, because of difficulties in accessing human central nervous system tissues. Microglia contribute to HIV reservoirs, but the molecular phenotype of HIV-infected microglia is poorly understood. We leveraged the unique "Last Gift" rapid autopsy program, in which people with HIV are closely followed until days or even hours before death. Microglial populations were heterogeneous regarding their gene expression profiles but showed similar chromatin accessibility landscapes. Despite ART, we detected occasional microglia containing cell-associated HIV RNA and HIV DNA integrated into open regions of the host's genome (∼0.005%). Microglia with detectable HIV RNA showed an inflammatory phenotype. These results demonstrate a distinct myeloid cell reservoir in the brains of people with HIV despite suppressive ART. Strategies for curing HIV and neurocognitive impairment will need to consider the myeloid compartment to be successful.

Indexed as

ChromatinHIV InfectionsMicrogliaAdultBrainFemaleGene ExpressionHIV-1HumansMaleMiddle AgedRNA, ViralViral LoadVirus LatencyChromatinRNA, Viral

Identifiers

PMID39060113
PMCPMC11282357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.